(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short percent of float has fallen 4.35% since its last report, with 6.88 million shares sold short, which is 0.22% of all regular shares available for trading. It would take traders 2.5 days to cover their short positions on average. The company has less short interest than most of its peers, with an average of 4.55%.
September 08, 2023 | 8:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Takeda Pharmaceutical's short interest has decreased, indicating a potentially more bullish sentiment towards the stock.
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. A decrease in short interest can signal that investors have become more bullish, which could potentially lead to an increase in the stock's price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100